Highline Wealth Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.51K Buy
118
+35
+42% +$3.29K ﹤0.01% 676
2026
Q1
$9.84K Buy
83
+48
+137% +$5.94K ﹤0.01% 458
2025
Q4
$4.43K Buy
35
+12
+52% +$1.56K ﹤0.01% 590
2025
Q3
$3.39K Sell
23
-8
-26% -$1.21K ﹤0.01% 697
2025
Q2
$4.85K Buy
31
+2
+7% +$317 ﹤0.01% 450
2025
Q1
$4.79K Buy
29
+15
+107% +$2.49K ﹤0.01% 434
2024
Q4
$2.29K Sell
14
-10
-42% -$1.79K ﹤0.01% 442
2024
Q3
$4.7K Buy
24
+10
+71% +$1.84K ﹤0.01% 347
2024
Q2
$2.43K Buy
14
+2
+17% +$333 ﹤0.01% 372
2024
Q1
$2.03K Hold
12
﹤0.01% 329
2023
Q4
$2.37K Sell
12
-45
-79% -$7.97K ﹤0.01% 289
2023
Q3
$9.92K Buy
57
+45
+375% +$8.17K 0.01% 187
2023
Q2
$2.07K Hold
12
﹤0.01% 225
2023
Q1
$2K Buy
12
+2
+20% +$328 ﹤0.01% 225
2022
Q4
$1.47K Hold
10
﹤0.01% 242
2022
Q3
$1.48K Buy
+10
New +$1.67K ﹤0.01% 228

Other funds holding ZTS

Highline Wealth Partners's ZTS Position: Q2 2026 in Review

Highline Wealth Partners increased its Zoetis (ZTS) stake by 42% in Q2 2026, buying an estimated $3.29K and bringing the position to 118 shares worth $8.51K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Highline Wealth Partners first reported a position in ZTS in Q3 2022 and has held it in 16 quarters since. The position peaked at $9.92K in Q3 2023. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Highline Wealth Partners held 118 shares of Zoetis worth $8.51K as of Q2 2026.
  • Highline Wealth Partners bought 35 Zoetis shares in Q2 2026, an estimated $3.29K.
  • Zoetis made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #676 holding.
  • Highline Wealth Partners first reported a position in Zoetis in Q3 2022 and has held it in 16 quarters since.
  • Highline Wealth Partners's Zoetis position peaked at $9.92K in Q3 2023.
  • 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.